vs
FGI Industries Ltd.（FGI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是FGI Industries Ltd.的1.2倍（$35.5M vs $30.5M），FGI Industries Ltd.净利率更高（-8.6% vs -304.2%，领先295.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -14.4%），FGI Industries Ltd.自由现金流更多（$2.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -0.5%）
FGI Industries Ltd是一家全球厨卫产品、家居收纳解决方案及家装用品的设计、制造与分销商，服务覆盖北美、欧洲及亚太地区的大型连锁零售商、家居专营店和电商平台。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
FGI vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$30.5M
营收增速更快
RXRX
高出696.1%
-14.4%
净利率更高
FGI
高出295.6%
-304.2%
自由现金流更多
FGI
多$49.6M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.5M | $35.5M |
| 净利润 | $-2.6M | $-108.1M |
| 毛利率 | 26.7% | 59.8% |
| 营业利润率 | -2.2% | -304.8% |
| 净利率 | -8.6% | -304.2% |
| 营收同比 | -14.4% | 681.7% |
| 净利润同比 | -553.1% | 39.6% |
| 每股收益（稀释后） | $-1.63 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FGIRXRX
| Q4 25 | $30.5M | $35.5M | ||
| Q3 25 | $35.8M | $5.2M | ||
| Q2 25 | $31.0M | $19.2M | ||
| Q1 25 | $33.2M | $14.7M | ||
| Q4 24 | $35.6M | $4.5M | ||
| Q3 24 | $36.1M | $26.1M | ||
| Q2 24 | $29.4M | $14.4M | ||
| Q1 24 | $30.8M | $13.8M |
净利润FGIRXRX
| Q4 25 | $-2.6M | $-108.1M | ||
| Q3 25 | $-1.7M | $-162.3M | ||
| Q2 25 | $-1.2M | $-171.9M | ||
| Q1 25 | $-629.1K | $-202.5M | ||
| Q4 24 | $-402.3K | $-178.9M | ||
| Q3 24 | $-550.1K | $-95.8M | ||
| Q2 24 | $163.6K | $-97.5M | ||
| Q1 24 | $-412.2K | $-91.4M |
毛利率FGIRXRX
| Q4 25 | 26.7% | 59.8% | ||
| Q3 25 | 26.5% | -183.8% | ||
| Q2 25 | 28.1% | -4.9% | ||
| Q1 25 | 26.8% | -48.0% | ||
| Q4 24 | 24.6% | -181.4% | ||
| Q3 24 | 25.8% | 53.7% | ||
| Q2 24 | 30.5% | 36.2% | ||
| Q1 24 | 27.4% | 19.1% |
营业利润率FGIRXRX
| Q4 25 | -2.2% | -304.8% | ||
| Q3 25 | 1.0% | -3327.6% | ||
| Q2 25 | -2.7% | -916.8% | ||
| Q1 25 | -3.9% | -1297.9% | ||
| Q4 24 | -3.5% | -4042.4% | ||
| Q3 24 | -0.2% | -377.1% | ||
| Q2 24 | -1.5% | -697.4% | ||
| Q1 24 | -1.0% | -698.4% |
净利率FGIRXRX
| Q4 25 | -8.6% | -304.2% | ||
| Q3 25 | -4.6% | -3135.3% | ||
| Q2 25 | -4.0% | -894.2% | ||
| Q1 25 | -1.9% | -1373.3% | ||
| Q4 24 | -1.1% | -3935.5% | ||
| Q3 24 | -1.5% | -367.5% | ||
| Q2 24 | 0.6% | -676.6% | ||
| Q1 24 | -1.3% | -662.4% |
每股收益（稀释后）FGIRXRX
| Q4 25 | $-1.63 | $-0.17 | ||
| Q3 25 | $-0.86 | $-0.36 | ||
| Q2 25 | $-0.64 | $-0.41 | ||
| Q1 25 | $-0.07 | $-0.50 | ||
| Q4 24 | $-0.38 | $-0.56 | ||
| Q3 24 | $-0.29 | $-0.34 | ||
| Q2 24 | $0.08 | $-0.40 | ||
| Q1 24 | $-0.04 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $17.3M | $1.1B |
| 总资产 | $69.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资FGIRXRX
| Q4 25 | $1.9M | $743.3M | ||
| Q3 25 | $1.9M | $659.8M | ||
| Q2 25 | $2.5M | $525.1M | ||
| Q1 25 | $1.2M | $500.5M | ||
| Q4 24 | $4.6M | $594.4M | ||
| Q3 24 | $3.0M | $427.6M | ||
| Q2 24 | $1.3M | $474.3M | ||
| Q1 24 | $3.3M | $296.3M |
总债务FGIRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益FGIRXRX
| Q4 25 | $17.3M | $1.1B | ||
| Q3 25 | $19.7M | $1.0B | ||
| Q2 25 | $21.3M | $919.1M | ||
| Q1 25 | $21.8M | $933.9M | ||
| Q4 24 | $22.3M | $1.0B | ||
| Q3 24 | $23.5M | $524.6M | ||
| Q2 24 | $23.8M | $584.4M | ||
| Q1 24 | $23.9M | $401.2M |
总资产FGIRXRX
| Q4 25 | $69.5M | $1.5B | ||
| Q3 25 | $73.0M | $1.4B | ||
| Q2 25 | $71.7M | $1.3B | ||
| Q1 25 | $68.5M | $1.3B | ||
| Q4 24 | $75.5M | $1.4B | ||
| Q3 24 | $74.7M | $726.5M | ||
| Q2 24 | $69.9M | $775.9M | ||
| Q1 24 | $68.6M | $557.8M |
负债/权益比FGIRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $2.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 7.5% | -133.1% |
| 资本支出强度资本支出/营收 | 0.2% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-212.5K | $-378.3M |
8季度趋势，按日历期对齐
经营现金流FGIRXRX
| Q4 25 | $2.3M | $-46.1M | ||
| Q3 25 | $-1.9M | $-117.4M | ||
| Q2 25 | $7.6M | $-76.4M | ||
| Q1 25 | $-7.4M | $-132.0M | ||
| Q4 24 | $617.4K | $-115.4M | ||
| Q3 24 | $-915.0K | $-59.2M | ||
| Q2 24 | $862.1K | $-82.2M | ||
| Q1 24 | $-8.0M | $-102.3M |
自由现金流FGIRXRX
| Q4 25 | $2.3M | $-47.3M | ||
| Q3 25 | $-2.1M | $-117.6M | ||
| Q2 25 | $7.4M | $-79.6M | ||
| Q1 25 | $-7.7M | $-133.8M | ||
| Q4 24 | $-214.1K | $-116.7M | ||
| Q3 24 | $-1.1M | $-63.8M | ||
| Q2 24 | $281.5K | $-83.4M | ||
| Q1 24 | $-8.6M | $-109.0M |
自由现金流率FGIRXRX
| Q4 25 | 7.5% | -133.1% | ||
| Q3 25 | -5.9% | -2272.5% | ||
| Q2 25 | 23.8% | -413.9% | ||
| Q1 25 | -23.3% | -907.4% | ||
| Q4 24 | -0.6% | -2567.7% | ||
| Q3 24 | -3.0% | -244.6% | ||
| Q2 24 | 1.0% | -578.5% | ||
| Q1 24 | -28.0% | -789.9% |
资本支出强度FGIRXRX
| Q4 25 | 0.2% | 3.5% | ||
| Q3 25 | 0.7% | 4.7% | ||
| Q2 25 | 0.7% | 16.4% | ||
| Q1 25 | 1.1% | 12.4% | ||
| Q4 24 | 2.3% | 28.6% | ||
| Q3 24 | 0.5% | 17.5% | ||
| Q2 24 | 2.0% | 8.2% | ||
| Q1 24 | 2.0% | 48.2% |
现金转化率FGIRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
RXRX
暂无分部数据
